Chemotherapy Drugs: Little known side effect YOU need to know about!

Written by James Arond-Thomas, MD


In January, 2005 it was reported that cancer has surpassed heart disease – forrepparttar first time – asrepparttar 113822 top killer of Americans younger than 85. In 2002,repparttar 113823 most recent year for which information is available, 476,009 Americans younger than 85 died of cancer, compared with 450,637 who died of heart disease. An estimated 1,372,910 new cancer cases and 570,260 cancer deaths are expected this year. Paclitaxel, a preferred treatment for lung and breast cancers, has a cancer-promoting risk as well…. Lung cancer remainsrepparttar 113824 biggest cancer killer, projected to claim 163,510 lives this year. Paclitaxel will be used inrepparttar 113825 attempt to saverepparttar 113826 lives of many of these patients. However, one little-known effect of Paclitaxel is that in a subset of these patients there will be up to a fivefold increase inrepparttar 113827 production of Interleukin – 8 (IL-8) – a cellular communication molecule that initiatesrepparttar 113828 growth of new blood vessels to feedrepparttar 113829 growing cancer. In other words, if you fall into this subset of patients, treatment using Paclitaxel alone may not be effective at preventing recurrence. NF-kB blockade enhances cancer killing ability of Paclitaxel! IL-8 is underrepparttar 113830 control of an inflammatory regulating protein called nuclear factor-kappa Beta (NF-kB). Whenrepparttar 113831 activation of NF-kB is blocked, IL-8 dries up, much like a faucet that has been turned off. Thus, blocking NF-kB activation enhancesrepparttar 113832 cancer killing ability of Paclitaxel. These results were seen with many types of cancer cells, including lung and esophageal cancer cells. Paclitaxel is NOTrepparttar 113833 Only Drug that Promotes Excessive NF-kB Paclitaxel is but one of a group of drugs that has this unwanted side-effect of activating NF-kB. Other drugs in this group include Doxorubicin, 5-Fluorouracil, Cisplatin, VP-16 (Etoposide), ARA-C, and Methotrexate. In addition, research demonstrates that excessive NF-kB activity contributes to cancer development inrepparttar 113834 following types of cancers: non-small cell lung cancer, pancreatic, primary liver, head and neck cancer, prostate, breast, esophageal, stomach, colon, Hodgkin’s disease, and multiple myeloma. Supportive treatment that improves chemotherapy effectiveness….. Paclitaxel, along withrepparttar 113835 other NF-kB activating chemotherapeutic drugs, is approved forrepparttar 113836 treatment of a wide range of cancers. It appears likely that they will continue to be used forrepparttar 113837 foreseeable future. If you are on (or considering using) Paclitaxel or one ofrepparttar 113838 other drugs in this group to treat cancer, there is a supportive treatment that you need to know about that improvesrepparttar 113839 effectiveness of these drugs and reduces your risk of having a cancer recurrence.

We have a Multi-Dimensional Approach to Reducing Inflammation that Complements and Enhancesrepparttar 113840 Impact of these Drugs! Atrepparttar 113841 Center for Learning about Healing in Ann Arbor, MI where I practice integrative medicine and behavioral oncology, I focus on multi-dimensional ways to empower patients to evaluate and change patterns of eating, behaving, thinking, and coping that are known to contribute to inflammatory reactions inrepparttar 113842 body. These methods complementrepparttar 113843 cancer killing effects of Paclitaxel, Doxorubicin, 5-FU, and other such drugs. Genomic Testing Can Clarify Your Specific Inflammatory Molecular Mechanisms that Sustain Your Cancer Inflammation is present before, and duringrepparttar 113844 life of a cancer. In cancer, inflammation is a pathological process characterized by injury or destruction of tissues caused by a variety of cellular and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. However, inflammation is also essential for tissue repair and tissue rebuilding. Genomic testing (easily performed with saliva or blood samples) allows us to create a personalized map of your inflammatory tendencies based on your genomic predispositions. This method is revolutionary because it allows you to regulate your genomic capabilities to your advantage, which then allows you to reducerepparttar 113845 expression of your inflammation-related genes.

Eazol - Eazol for Chronic Pain Relief

Written by Ratliff J


Most likely, you or someone you know suffers from some form of joint pain. Withrepparttar recent removal of VIOXX and Celebrex fromrepparttar 113821 market, millions of people are searching for an all-natural alternative. Eazol™ isrepparttar 113822 ONLY pain relief health supplement that includes a complete list of active botanicals in one easy to take supplement.

Eazol can

Cont'd on page 2 ==>
 
ImproveHomeLife.com © 2005
Terms of Use